Navigation Links
New Data: Efficacy and Responder Analyses of Divigel(R) (estradiol gel) 0.1 percent for the Treatment of Menopause
Date:6/30/2009

t of hot flashes associated with menopause."

About the Study

The responder analysis presented at ACOG was a secondary analysis of the Divigel(R) phase III efficacy and safety study published earlier this year in the journal Menopause. A total of 488 postmenopausal women were evaluated in this 12-week efficacy and safety study, comparing placebo to the low-dose transdermal Divigel(R) at doses of 1.0 mg/day, 0.5 mg/day and 0.25 mg/day estradiol. Endpoints included the change from baseline in daily frequency and severity of moderate to severe hot flashes. The study also evaluated common adverse events and tolerability at the application site. Divigel(R) showed statistically significant improvements compared with placebo as early as week two that were maintained throughout treatment. Divigel(R) significantly decreased the frequency and severity of MSVMS at all doses evaluated in this trial. The most common treatment-related adverse events were breast tenderness and postmenopausal bleeding.

"Divigel(R) offers women the lowest effective FDA-approved dose of estrogen therapy for MSVMS in post-menopausal women and dosing flexibility with availability of three different strengths (0.25 mg estradiol/day, 0.5 mg estradiol/day and 1.0 mg estradiol/day) giving physicians greater ability to individualize treatment for each woman," added Dr. Koltun.

About Divigel(R)

Divigel(R) is indicated for the treatment of MSVMS associated with menopause. The estrogen in Divigel(R) is derived from plant sources and is identical to the primary estrogen produced by a woman's ovaries before menopause. Certain older oral estrogen therapies contain conjugated estrogens derived from the urine of pregnant mares. Divigel(R) is applied to the skin and takes a more direct route to the systemic blood stream, bypassing the liver. It is a quick-drying gel that is odorless when dry and is available in convenient, indiv
'/>"/>

SOURCE Upsher-Smith Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Clinical trial data: Safety/efficacy of concomitant formoterol fumarate/tiotropium treating COPD
2. Five Hospitals to Share Patient Data: ICW Connects Regional Medical Centers and University Facility
3. New Government Data: Mail-Service Pharmacies Grow, But Public Programs Lag Behind
4. Shining light on sciences dark data: New venture ensures a fuller scientific record
5. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
6. New Study Data: JANUVIA™ (sitagliptin) Significantly Reduced Blood Sugar Levels and Was Not Associated with Hypoglycemia in Elderly Patients with Type 2 Diabetes
7. New Data: Advanced Pharmacy Model Significantly Reduces Gaps in Care for Patients with Chronic and Complex Conditions; Improves Clinical and Financial Outcomes
8. Promising Three-year Data: Saving Limbs With Drug-Eluting Stents
9. Data: Actual imaging use far below Presidents rec. 95 percent utilization rate for Medicare
10. Data: Actual imaging use far below presidents recommended 95 percent utilization rate for Medicare
11. Radiation and drug combo helps boost efficacy of lung cancer treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2009)... more likely to try alcohol, illegal drugs , , THURSDAY, ... smoking cigarettes is riskier than using illicit drugs or ... perception may increase the likelihood that they,ll experiment with ... "We are on the right track with cigarette smoking ... the dangers of other substances," Pamela S. Hyde, administrator ...
(Date:12/17/2009)... nurses now able to access trusted medical information using virtually ... ... MA (PRWEB) December 17, 2009 -- Skyscape, Inc., the world’s ... and the Internet, has launched a mobile clinical decision application ... are now available on most smart phone devices, making the ...
(Date:12/17/2009)... 17 Reportlinker.com announces that a ... its catalogue: ,, http://www.reportlinker.com/p0169956/Top-Ten-Worlds-Leading-Animal-Health-Companies.html ... the animal health industry executives with strategically ... to the development and implementation of effective ... objectives include: ,, To establish ...
(Date:12/17/2009)... Today, CDC,s Morbidity and Mortality Weekly Report (MMWR) ... state-level epidemiologists has decreased steadily since 2004, with ... There was also a substantial decrease in core ... capacity for bioterrorism and emergency response. ... health, substance abuse, and oral health, basic epidemiology ...
(Date:12/17/2009)... -- Good Samaritan Hospital is changing the way women ... launch of the Good Samaritan Hospital Women,s Center For ... to help treat two common medical problems - lack ... bladder, uterus or rectum (pelvic organ prolapse). Three out ... and one out of three may experience pelvic organ ...
Breaking Medicine News(10 mins):Health News:Teens Think Smoking More Dangerous Than Drinking, Drugs 2Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 2Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 3Health News:Skyscape Offers Medical Professionals Real Time Clinical Decision Application on Google Android 4Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 2Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 3Health News:Reportlinker Adds Top Ten World's Leading Animal Health Companies 4Health News:CSTE National Assessment Finds Critical Public Health Disease Surveillance Capacity Lacking 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 2Health News:Good Samaritan Hospital Launches Women's Center For Bladder & Pelvic Health 3
... NEW YORK, July 3 Attorneys representing more than ... recovery and debris clean-up personnel who became ill after ... site following the collapse,of the World Trade Center Towers ... responsible for the litigation of those cases that the ...
... of disease in developing countries, study suggests, , , THURSDAY, ... where breast-feeding is a necessity, and HIV is rampant, ... be reduced if infants were first fed a freeze-dried ... potentially destroy the deadly virus. , But that hope ...
... July 3 Dr. Thomas Hassell, former,global vice ... leading,vaccine company, has joined IAVI as vice president ... will lead IAVI,s product development efforts,that are aimed ... the organization,s vaccine discovery programs., Dr. Hassell ...
... Senators,Hutchison and Cornyn for blocking bill to protect ... July 3 AARP Texas joined,forces today with ... Bailey,Hutchison and John Cornyn to reconsider and support ... cut to doctors who treat Medicare patients, keep,Medicare ...
... NEW YORK, July 3 Mergent, Inc., administrator ... indexes for the,HealthShares(TM) Exchange Traded Funds, today announced ... on Wednesday July 9, 2008: ISTA,Pharmaceuticals (Nasdaq: ... in the HealthShares(TM) Ophthalmology Index. Jerini AG is ...
... benefits of restricted calorie diets, study finds , , THURSDAY, ... in red wine known as resveratrol appears to protect ... old, new animal research reveals. , "It,s very hard ... benefits of red wine directly, because red wine has ...
Other Medicine News:Health News:9/11 Workers Refute City's Allegation of Discovery Abuse and Malingering 2Health News:9/11 Workers Refute City's Allegation of Discovery Abuse and Malingering 3Health News:Freeze-Dried Formula May Block HIV Virus in Breast Milk 2Health News:Leading Vaccine Expert Joins IAVI 2Health News:Leading Vaccine Expert Joins IAVI 3Health News:AARP, Texas Medical Association Join Forces to Urge Passage of Bill Protecting Access to Doctors and Improving Medicare 2Health News:AARP, Texas Medical Association Join Forces to Urge Passage of Bill Protecting Access to Doctors and Improving Medicare 3Health News:Mergent, Inc. Announces Changes to the HealthShares(TM) Ophthalmology Index 2Health News:Compound in Red Wine Fights Ravages of Age 2Health News:Compound in Red Wine Fights Ravages of Age 3
(Date:12/16/2009)... According to Millennium Research Group (MRG), the global ... US minimally invasive spinal fusion market will expand ... 12% through 2014, reimbursement concerns in certain segments ... previously had been forecast at almost 20%. ,, ... Technologies 2010 report finds that ...
(Date:12/16/2009)... Wound Management Technologies, Inc. (OTC ... of specialty medical products, announced today that ... toward productization of its patented orthopedic bone ... products to be introduced in Q3 2010, ... a multi-billion dollar international market. ,, "Resorbable ...
(Date:12/16/2009)... 16 DATATRAK International, Inc. (OTCQX: ... on global eClinical solutions for the clinical ... its version 9.0 eClinical Software. This ... product and service delivery and introduces two ... offering: the DATATRAK Learning Center(TM) and the ...
Breaking Medicine Technology:Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 2Reimbursement Difficulties With TranS1's AxiaLIF and NuVasive's XLIF Have Sceptics Talking 3Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 2Wound Management Technologies, Inc. Targets Multi-Billion Dollar Biomaterials Market; Releases Update on Resorbable Orthopedics 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 2DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 3DATATRAK's eClinical(TM) 9.0 Software Release furthers Vision of DATATRAK ONE(TM) 4Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 1Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 2Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 3Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 4Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin 28R 29 in Subgroup Analyses from Its Phase 3 Study for the Tr 12427 5FREE Wash Your Hands Song from Edutunes com Teaches Children How to Stay Healthy 47694 1Twinlab 28R 29 Teams Up With The Vitamin Shoppe to Debut Mass Fuel 28R 29 Xtreme 47689 1Twinlab 28R 29 Teams Up With The Vitamin Shoppe to Debut Mass Fuel 28R 29 Xtreme 47689 2Twinlab 28R 29 Teams Up With The Vitamin Shoppe to Debut Mass Fuel 28R 29 Xtreme 47689 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: